Barbara Bruno Fagundes Marques
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Barbara Bruno Fagundes Marques has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Ricardo Guimarães Fischer
Universidade do Estado do Rio de Janeiro (Uerj), aculdade de Odontologia, Departamento de Procedimentos Clínicos Integrados. Rio de Janeiro (RJ), Brasil
4 shared publications - Eduardo Muniz Barretto Tinoco
Universidade do Estado do Rio de Janeiro
3 shared publications Eduardo Muniz Barretto Tinoco
2 shared publicationsJustine Monteiro Monnerat Tinoco
2 shared publications- Justine Monteiro Monnerat Tinoco
Department of Endodontology, School of Dentistry, State University of Rio de Janeiro, Rio de Janeiro, RJ 20551-030, Brazil
2 shared publications Taísa Coelho Guimarães
2 shared publications
Latest Publications
- Open Access
- 5 August 2026
- Published by Zeppelini Editorial e Comunicacao in Journal of Oral Diagnosis
- Vol. 11
Medication-related osteonecrosis of the jaw: an emerging adverse effect of rituximab therapy – a case report
Medication-related osteonecrosis of the jaw (MRONJ) is traditionally linked to antiresorptive and antiangiogenic therapies. However, recent evidence suggests that biologic agents, including monoclonal antibodies (mAbs), may also be associated with osteonecrosis. This study reports a case of MRONJ following Rituximab therapy in a patient after treating a non-Hodgkin lymphoma, emphasizing the emergence of this adverse effect in non-antiresorptive protocols. A female patient, following R-CHOP therapy, presented with a painless lesion characterized by bone exposure and suppuration in the periapical region of teeth 43 and 44. Initial management combined professional prophylaxis, antiseptic therapy, debridement, and endodontic treatment under antibiotic coverage. However, the lesion proved refractory, resulting in persistent suppuration and spontaneous bone sequestration after 5 months, which was subsequently treated surgically with adjuvant antibiotic therapy and photobiomodulation. Histopathological examination successfully ruled out malignancy. This clinical outcome highlights the increased susceptibility to bone necrosis in patients undergoing this specific immunotherapy regimen. Ultimately, the early identification of this non-antiresorptive-induced bone necrosis pathobiology is essential to facilitate conservative management and minimize the requirement for extensive surgical interventions.
- 5 August 2026
- Published by Zeppelini Editorial e Comunicacao in Journal of Oral Diagnosis
- Vol. 11
Open AccessMedication-related osteonecrosis of the jaw: an emerging adverse effect of rituximab therapy – a case report
Medication-related osteonecrosis of the jaw (MRONJ) is traditionally linked to antiresorptive and antiangiogenic therapies. However, recent evidence suggests that biologic agents, including monoclonal antibodies (mAbs), may also be associated with osteonecrosis. This study reports a case of MRONJ following Rituximab therapy in a patient after treating a non-Hodgkin lymphoma, emphasizing the emergence of this adverse effect in non-antiresorptive protocols. A female patient, following R-CHOP therapy, presented with a painless lesion characterized by bone exposure and suppuration in the periapical region of teeth 43 and 44. Initial management combined professional prophylaxis, antiseptic therapy, debridement, and endodontic treatment under antibiotic coverage. However, the lesion proved refractory, resulting in persistent suppuration and spontaneous bone sequestration after 5 months, which was subsequently treated surgically with adjuvant antibiotic therapy and photobiomodulation. Histopathological examination successfully ruled out malignancy. This clinical outcome highlights the increased susceptibility to bone necrosis in patients undergoing this specific immunotherapy regimen. Ultimately, the early identification of this non-antiresorptive-induced bone necrosis pathobiology is essential to facilitate conservative management and minimize the requirement for extensive surgical interventions.
- Open Access
- 31 March 2026
- Published by Qeios Ltd
Review of: "Optimization of Pre-Sampling Conditions for Salivary Genomic DNA Extraction: A Single-Donor Analysis"
- 31 March 2026
- Published by Qeios Ltd
Open AccessReview of: "Optimization of Pre-Sampling Conditions for Salivary Genomic DNA Extraction: A Single-Donor Analysis"
- Open Access
- 29 March 2026
- Published by Elsevier in Clinical Immunology Communications
- Vol. 9, 95-101
Salivary cytokine profiles in acute and convalescent SARS-CoV-2 infection: A pilot study
- 29 March 2026
- Published by Elsevier in Clinical Immunology Communications
- Vol. 9, 95-101
Open AccessSalivary cytokine profiles in acute and convalescent SARS-CoV-2 infection: A pilot study
- Open Access
- 31 December 2025
- Published by Universidade Federal do Tocantins in Revista de Patologia do Tocantins
- Vol. 25 (4)
THE IMPACT OF DENTAL TREATMENT ON ORAL MICROBIOTA OF A PATIENT WITH SJÖGREN'S DISEASE: A CLINICAL CASE REPORT
A Doença de Sjögren (SD) é uma desordem sistêmica crônica autoimune caracterizada por infiltração de linfócitos nas glândulas exócrinas, atingindo principalmente as glândulas lacrimais e salivares, sendo a xeroftalmia e a xerostomia os sintomas mais prevalentes. A xerostomia provoca mudanças na microbiota oral, podendo levar a quadros de disbiose e ao desenvolvimento de desordens orais. Este trabalho relata o caso clínico de uma paciente do sexo feminino, 38 anos, que procurou tratamento odontológico devido à insatisfação com a estética do sorriso. Durante a anamnese, relatou diagnóstico prévio de SD. Foi realizada sialometria estimulada para avaliar o fluxo salivar, com média de 0,1 ml/min de saliva produzida. Com o intuito de avaliar a alteração da microbiota dessa paciente ao longo do tratamento, uma amostra de saliva foi diluída e cultivada em placas contendo CHROMagar Candida, no início do tratamento e ao final dos tratamentos de adequação do meio bucal. Observou-se alteração das espécies prevalentes no início e ao final das intervenções odontológicas. Corroborando com dados que demonstram que tratamentos odontológicos para promoção e adequação do meio bucal em pacientes com SD, sem o uso de agentes antimicrobianos, podem provocar mudanças na microbiota oral desfazendo quadros disbióticos. PALAVRAS-CHAVE: Doença de Sjögren; Candida; Disbiose.
- 31 December 2025
- Published by Universidade Federal do Tocantins in Revista de Patologia do Tocantins
- Vol. 25 (4)
Open AccessTHE IMPACT OF DENTAL TREATMENT ON ORAL MICROBIOTA OF A PATIENT WITH SJÖGREN'S DISEASE: A CLINICAL CASE REPORT
A Doença de Sjögren (SD) é uma desordem sistêmica crônica autoimune caracterizada por infiltração de linfócitos nas glândulas exócrinas, atingindo principalmente as glândulas lacrimais e salivares, sendo a xeroftalmia e a xerostomia os sintomas mais prevalentes. A xerostomia provoca mudanças na microbiota oral, podendo levar a quadros de disbiose e ao desenvolvimento de desordens orais. Este trabalho relata o caso clínico de uma paciente do sexo feminino, 38 anos, que procurou tratamento odontológico devido à insatisfação com a estética do sorriso. Durante a anamnese, relatou diagnóstico prévio de SD. Foi realizada sialometria estimulada para avaliar o fluxo salivar, com média de 0,1 ml/min de saliva produzida. Com o intuito de avaliar a alteração da microbiota dessa paciente ao longo do tratamento, uma amostra de saliva foi diluída e cultivada em placas contendo CHROMagar Candida, no início do tratamento e ao final dos tratamentos de adequação do meio bucal. Observou-se alteração das espécies prevalentes no início e ao final das intervenções odontológicas. Corroborando com dados que demonstram que tratamentos odontológicos para promoção e adequação do meio bucal em pacientes com SD, sem o uso de agentes antimicrobianos, podem provocar mudanças na microbiota oral desfazendo quadros disbióticos. PALAVRAS-CHAVE: Doença de Sjögren; Candida; Disbiose.
- Open Access
- 11 February 2023
- Published by MDPI AG in Metabolites
- Vol. 13 (2) , 263
Salivary Metabolomic Analysis Reveals Amino Acid Metabolism Shift in SARS-CoV-2 Virus Activity and Post-Infection Condition
The SARS-CoV-2 virus primarily infects salivary glands suggesting a change in the saliva metabolite profile; this shift may be used as a monitoring instrument during SARS-CoV-2 infection. The present study aims to determine the salivary metabolomic profile of patients with and post-SARS-CoV-19 infection. Patients were without (PCR−), with SARS-CoV-2 (PCR+), or post-SARS-CoV-2 infection. Unstimulated whole saliva was collected, and the 1H spectra were acquired in a 500 MHz Bruker nuclear magnetic resonance spectrometer at 25 °C. They were subjected to multivariate analysis using principal component analysis (PCA) and partial least squares discriminant analysis (PLS-DA), as well as univariate analysis through t-tests (SPSS 20.0, IL, USA), with a significance level of p < 0.05. A distinction was found when comparing PCR− subjects to those with SARS-CoV-2 infection. When comparing the three groups, the PLS-DA cross-validation presented satisfactory accuracy (ACC = 0.69, R2 = 0.39, Q2 = 0.08). Seventeen metabolites were found in different proportions among the groups. The results suggested the downregulation of major amino acid levels, such as alanine, glutamine, histidine, leucine, lysine, phenylalanine, and proline in the PCR+ group compared to the PCR− ones. In addition, acetate, valerate, and capronic acid were higher in PCR− patients than in PCR+. Sucrose and butyrate were higher in post-SARS-CoV-2 infection compared to PCR−. In general, a reduction in amino acids was observed in subjects with and post-SARS-CoV-2 disease. The salivary metabolomic strategy NMR-based was able to differentiate between non-infected individuals and those with acute and post-SARS-CoV-19 infection.
- 11 February 2023
- Published by MDPI AG in Metabolites
- Vol. 13 (2) , 263
Open AccessSalivary Metabolomic Analysis Reveals Amino Acid Metabolism Shift in SARS-CoV-2 Virus Activity and Post-Infection Condition
The SARS-CoV-2 virus primarily infects salivary glands suggesting a change in the saliva metabolite profile; this shift may be used as a monitoring instrument during SARS-CoV-2 infection. The present study aims to determine the salivary metabolomic profile of patients with and post-SARS-CoV-19 infection. Patients were without (PCR−), with SARS-CoV-2 (PCR+), or post-SARS-CoV-2 infection. Unstimulated whole saliva was collected, and the 1H spectra were acquired in a 500 MHz Bruker nuclear magnetic resonance spectrometer at 25 °C. They were subjected to multivariate analysis using principal component analysis (PCA) and partial least squares discriminant analysis (PLS-DA), as well as univariate analysis through t-tests (SPSS 20.0, IL, USA), with a significance level of p < 0.05. A distinction was found when comparing PCR− subjects to those with SARS-CoV-2 infection. When comparing the three groups, the PLS-DA cross-validation presented satisfactory accuracy (ACC = 0.69, R2 = 0.39, Q2 = 0.08). Seventeen metabolites were found in different proportions among the groups. The results suggested the downregulation of major amino acid levels, such as alanine, glutamine, histidine, leucine, lysine, phenylalanine, and proline in the PCR+ group compared to the PCR− ones. In addition, acetate, valerate, and capronic acid were higher in PCR− patients than in PCR+. Sucrose and butyrate were higher in post-SARS-CoV-2 infection compared to PCR−. In general, a reduction in amino acids was observed in subjects with and post-SARS-CoV-2 disease. The salivary metabolomic strategy NMR-based was able to differentiate between non-infected individuals and those with acute and post-SARS-CoV-19 infection.
- Open Access
- 29 April 2022
- Published by FapUNIFESP (SciELO) in Brazilian Dental Journal
- Vol. 33 (2) , 68-72
SARS-COV-2 detection in saliva and nasopharyngeal swabs using RT-PCR was similar
The World Health Organization has declared the widespread spread of SARS-CoV-2 and its associated disease (COVID-19) a public health emergency. The standard gold test for detecting the virus is the RT-PCR, performed from nasopharyngeal swab (NPS) samples. However, this test may be uncomfortable for the patient and requires specific training and attire from the health professional responsible for collecting the sample. Therefore, the search for alternative ways to collect samples that may be used in the diagnosis of COVID-19 is relevant. This study aimed to compare the results obtained from NPS and saliva samples. NPS and saliva samples were collected from 189 symptomatic outpatients suspected of COVID-19, who came to Piquet Carneiro Polyclinic. RNA extraction was performed using the Bio-Gene DNA/RNA Viral Extraction kit (Bioclin®). Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) reactions used the Molecular SARS-CoV-2 (E / RP) kit (Bio-Manguinhos). The results indicated that 142 showed a non-detectable result (ND), while 47 showed a detectable result (D). Among the 142 "ND", 137 (94.4%) saliva samples obtained the same result, while 5 samples (3.4%) were "D". Among the 47 "D" swab samples, 35 (74.4%) showed the same result in the saliva samples. The sensitivity of the saliva test was 0.74 and the specificity was 0.97. The positive predictive value was 0.88 while the negative predictive value was 0.92. The results showed that detection of Sars-CoV-2 using saliva samples showed high sensitivity and specificity compared to nasopharyngeal swabs.
- 29 April 2022
- Published by FapUNIFESP (SciELO) in Brazilian Dental Journal
- Vol. 33 (2) , 68-72
Open AccessSARS-COV-2 detection in saliva and nasopharyngeal swabs using RT-PCR was similar
The World Health Organization has declared the widespread spread of SARS-CoV-2 and its associated disease (COVID-19) a public health emergency. The standard gold test for detecting the virus is the RT-PCR, performed from nasopharyngeal swab (NPS) samples. However, this test may be uncomfortable for the patient and requires specific training and attire from the health professional responsible for collecting the sample. Therefore, the search for alternative ways to collect samples that may be used in the diagnosis of COVID-19 is relevant. This study aimed to compare the results obtained from NPS and saliva samples. NPS and saliva samples were collected from 189 symptomatic outpatients suspected of COVID-19, who came to Piquet Carneiro Polyclinic. RNA extraction was performed using the Bio-Gene DNA/RNA Viral Extraction kit (Bioclin®). Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) reactions used the Molecular SARS-CoV-2 (E / RP) kit (Bio-Manguinhos). The results indicated that 142 showed a non-detectable result (ND), while 47 showed a detectable result (D). Among the 142 "ND", 137 (94.4%) saliva samples obtained the same result, while 5 samples (3.4%) were "D". Among the 47 "D" swab samples, 35 (74.4%) showed the same result in the saliva samples. The sensitivity of the saliva test was 0.74 and the specificity was 0.97. The positive predictive value was 0.88 while the negative predictive value was 0.92. The results showed that detection of Sars-CoV-2 using saliva samples showed high sensitivity and specificity compared to nasopharyngeal swabs.
- Open Access
- 28 December 2021
- Published by Wiley in Oral Diseases
- Vol. 28 (S2) , 2474-2480
Reducing the viral load of SARS‐CoV‐2 in the saliva of patients with COVID‐19
Objective: To evaluate the reduction in the salivary viral load using oral antiseptic mouthwashes in patients testing positive for COVID‐19.Methods: Sixty‐three individuals were recruited after testing positive for COVID‐19 by real‐time RT‐PCR assay and divided into 5 groups. Group 1 received sterile water, group 2 received 1.5% hydrogen peroxide solution (HP), group 3 received 0.12% chlorhexidine (CHX), group 4 received 0.1% sodium hypochlorite solution (NaClO), and group 5 received sequential rinses using CHX and HP. After collecting the initial saliva sample, individuals were asked to use the designated mouthwash for 1 min. Additional saliva samples were collected immediately after rinsing, 15, and 30 min after rinsing. Real‐time RT‐PCR assays for RNA detection of SARS‐CoV‐2 were performed on the saliva samples.Results: There were no significant differences among the experimental groups and the control group in any period. Compared to the baseline values, there was a significant reduction in the number of copies of SARS‐CoV‐2 after 30 min in group 2 and immediately after the initial mouthwash in group 4.Conclusions: No experimental group demonstrated a significant reduction in the viral load compared to the control group.
- 28 December 2021
- Published by Wiley in Oral Diseases
- Vol. 28 (S2) , 2474-2480
Open AccessReducing the viral load of SARS‐CoV‐2 in the saliva of patients with COVID‐19
Objective: To evaluate the reduction in the salivary viral load using oral antiseptic mouthwashes in patients testing positive for COVID‐19.Methods: Sixty‐three individuals were recruited after testing positive for COVID‐19 by real‐time RT‐PCR assay and divided into 5 groups. Group 1 received sterile water, group 2 received 1.5% hydrogen peroxide solution (HP), group 3 received 0.12% chlorhexidine (CHX), group 4 received 0.1% sodium hypochlorite solution (NaClO), and group 5 received sequential rinses using CHX and HP. After collecting the initial saliva sample, individuals were asked to use the designated mouthwash for 1 min. Additional saliva samples were collected immediately after rinsing, 15, and 30 min after rinsing. Real‐time RT‐PCR assays for RNA detection of SARS‐CoV‐2 were performed on the saliva samples.Results: There were no significant differences among the experimental groups and the control group in any period. Compared to the baseline values, there was a significant reduction in the number of copies of SARS‐CoV‐2 after 30 min in group 2 and immediately after the initial mouthwash in group 4.Conclusions: No experimental group demonstrated a significant reduction in the viral load compared to the control group.
- Open Access
- 3 August 2021
- Published by Wiley in Oral Diseases
- Vol. 28 (S2) , 2417-2422
Morphological alterations in tongue epithelial cells infected by SARS‐CoV‐2: A case–control study
Objective The aim of the present case–control study was to evaluate the morphological aspects of the epithelial cells from the dorsum of the tongue and the expression of the SARS-CoV-2 Spike protein in these cells, in patients with and without COVID-19 infection. Methods 24 individuals with at least one symptom of COVID-19 were recruited among inpatients from Hospital Universitário Pedro Ernesto (Rio de Janeiro, Brazil). 14 patients who tested positive for COVID-19 by RT-PCR were included in the case group, and 10 patients who tested negative were included in the control group. Cytological smears from the dorsum of the tongue were obtained from all patients and analyzed using immunohistochemistry directed against SARS-CoV-2-Spike protein. Morphological changes in epithelial cells were analyzed using light microscopy. Results Immunohistochemistry showed that 71% of the COVID-19 patients presented epithelial cells positive for the presence of the SARS-CoV-2 Spike protein, and all cells coming from patients in the control group were negative. Cytological analysis showed significant differences when comparing epithelial cells from COVID-19-positive and COVID-19-negative patients. Conclusion COVID-19 may generate dimensional changes in tongue epithelial cells; however, further studies are necessary to understand how this happens.
- 3 August 2021
- Published by Wiley in Oral Diseases
- Vol. 28 (S2) , 2417-2422
Open AccessMorphological alterations in tongue epithelial cells infected by SARS‐CoV‐2: A case–control study
Objective The aim of the present case–control study was to evaluate the morphological aspects of the epithelial cells from the dorsum of the tongue and the expression of the SARS-CoV-2 Spike protein in these cells, in patients with and without COVID-19 infection. Methods 24 individuals with at least one symptom of COVID-19 were recruited among inpatients from Hospital Universitário Pedro Ernesto (Rio de Janeiro, Brazil). 14 patients who tested positive for COVID-19 by RT-PCR were included in the case group, and 10 patients who tested negative were included in the control group. Cytological smears from the dorsum of the tongue were obtained from all patients and analyzed using immunohistochemistry directed against SARS-CoV-2-Spike protein. Morphological changes in epithelial cells were analyzed using light microscopy. Results Immunohistochemistry showed that 71% of the COVID-19 patients presented epithelial cells positive for the presence of the SARS-CoV-2 Spike protein, and all cells coming from patients in the control group were negative. Cytological analysis showed significant differences when comparing epithelial cells from COVID-19-positive and COVID-19-negative patients. Conclusion COVID-19 may generate dimensional changes in tongue epithelial cells; however, further studies are necessary to understand how this happens.